Since aromatase inhibitors are comperatively expensive drugs, they can be preferred temporary treatment in women who desire to keep their uterus or who are not suitable for the surgical intervention [28] in women with unexplained infertility with uterine myoma, and also in obese women who fail to respond to GnRHa therapy [29]. This evidence concerns the gene CYP19A1 and Infertility.